Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Radiotherapy with 90Y-Besilesomab Prior to ASCT in Multiple Myeloma
NCT00637767Phase 2Terminated
- Sponsor
- University of Southampton
- Start
- Dec 2007
- Primary completion
- Oct 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 90Y-besilesomab in multiple myeloma (MM), sponsored by University of Southampton. Started Dec 2007; status: terminated.
02
Drugs
90Y-besilesomab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00637767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637767.